LINC 2016 programme

Find all topics and speakers listed below.

Room 1 - Main Arena 1

22 events
  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Symposium: Treatment strategies for complex disease in the SFA/Pop

    Moderator:
    Dierk Scheinert
    Panel:
    Ramon Varcoe, Brian DeRubertis, Gary Ansel, Lawrence Garcia, Jihad Mustapha, Thomas Zeller
    1. -

      Introduction by the moderator and overview of complex SFA disease: calcium, long lesions, reintervention

        Dierk Scheinert
    2. -

      Treatment strategies for calcium

        Thomas Zeller
    3. -

      Treatment strategies for long lesions > 20 cm

        Donald Jacobs
    4. -

      Live case transmission from Leipzig

    5. -

      SUPERSUB: Results of subintimal SUPERA cohort in CLI patients

        Luis Mariano Palena
    6. -

      Economic fempop treatment depends on device choice

        Michael Jaff
    7. -

      Treatment strategies for reintervention (catastrophic failure)

        Jihad Mustapha
    8. -

      Live case transmission from Leipzig

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Changing paradigms and future concepts in peripheral interventions – how far have we come?

    Moderator:
    Dierk Scheinert, Ramon Varcoe
    Panel:
    Christopher Owens, Jihad Mustapha, Erich Minar, Thomas Zeller, Ayman Al-Sibaie
    1. -

      DRUG-COATED BALLOONS: LATEST DATA FROM CLINICAL TRAILS

    2. -

      Angiographic and clinical 6 months results of the CONSEQUENT trial

        Thomas Albrecht
    3. -

      AcoArt Trial – 12 months results with the Orchid DEB in femoropoliteal lesions

    4. -

      Latest insights from the LEVANT II study and subgroup analysis

        Dierk Scheinert
    5. -

      IN.PACT SFA trial – 2 year outcomes

        Peter Schneider
    6. -

      Update on the German/US budget impact model on the cost-effectiveness of DCB in the German & US healthcare systems

        Thomas Zeller
    7. -

      DRUG-COATED BALLOONS: ALSO THE PRIMARY SOLUTION FOR LONG LESIONS?

    8. -

      Drug-coated balloons: Also the primary solution for long lesions? Pro:

        Francesco Liistro
    9. -

      Drug-coated balloons: Also the primary solution for long lesions? Contra:

        Michael Dake
    10. -

      Panel discussion

    11. -

      ADJUNCTIVE TREATMENT MODALITIES FOR COMPLEX LESIONS

    12. -

      From pre-dilatation to debulking: what, when and why to add more upon plain DCB

        Gunnar Tepe
    13. -

      Live case transmission from Leipzig

    14. -

      When DCB is not enough: Is there a need for new DAART study?

        Thomas Zeller
    15. -

      FUTURE CONCEPTS FOR DRUG DELIVERY

    16. -

      DANCE trial

        Christopher Owens
    17. -

      THE LATEST IN IMPLANT TECHNOLOGY

    18. -

      Eluvia 12 months data

        Stefan Müller-Hülsbeck
    19. -

      RAPID trial: A RCT comparing legflow DCB versus POBA followed by SUPERA stenting in “real world” long-segment femoropopliteal lesions

        Jean-Paul de Vries
    20. -

      Discussion

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Symposium: Drug elution – leave the right thing behind. Debating evidence to provide the answers.

    Moderator:
    Michael Dake
    Panel:
    Francesco Liistro, Gary Ansel, Andrew Holden
    1. -

      Introduction by the moderator

    2. -

      Why my stent usage is increasing

        Andrew Holden
    3. -

      Surgical bypass or Zilver PTX – 12-month preliminary data

        Marc Bosiers
    4. -

      Live case transmission from Leipzig

    5. -

      Leave the right thing behind - patterns of restenosis

        Gary Ansel
    6. -

      Live case transmission from Dendermonde

    7. -

      An evidence based approach: Bare stents and balloons are obsolete

        Konstantinos Katsanos
    8. -

      Summary of the symposium, discussion and questions

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Lunch

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Symposium: From simple to complex lesions: Is the robust IN.PACT DCB evidence shifting the SFA treatment paradigm?

    Moderator:
    Thomas Zeller, Marianne Brodmann
    Panel:
    Peter Schneider, Gary Ansel, Robert Melder, Fabrizio Fanelli
    1. -

      Deep dive: IN.PACT SFA 2 year outcomes

        Peter Schneider
    2. -

      A real-world experience: 12-month outcomes from IN.PACT Global Long Lesions imaging cohort

        Gunnar Tepe
    3. -

      Live case transmission from Cotignola

    4. -

      The vexing problem of ISR: Is IN.PACT DCB the solution? 12 months outcomes from IN.PACTGlobal study ISR imaging cohort

        Gary Ansel
    5. -

      Understanding the science behind the latest evidence

        Robert Melder
    6. -

      How IN.PACT DCB evidence has changed my SFA treatment algorithm

        Fabrizio Fanelli
    7. -

      Live case transmission from Leipzig

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    Controversial issues, new insights and pioneering solution for Critical Limb Ischemia

    Moderator:
    Dierk Scheinert, Peter Schneider
    Panel:
    Ramon Varcoe, George Adams, Mohammad AlTwalah, Sebastian Debus, Steven Kum
    1. -

      First-line treatment strategies in patients with critical limb ischemia: One year outcomes from the CRITISCH registry

        Theodosios Bisdas
    2. -

      Explaining the discrepancy between low patency and higher limb salvage rates after revascularization for CLI: Does perfusion matter or not?

        Peter Schneider
    3. -

      CLINICAL TRAIL UPDATE

    4. -

      The 3 year outcomes of endoluminal bypass for patients with CLI: The Spanish experience

        Jorge Fernández Noya
    5. -

      The NANOCROSS study: final 12 month results

        Marc Bosiers
    6. -

      1-year results of the PES-BTK-70 study: investigating a self-expanding paclitaxel-eluting stent in BTK arteries

        Patrick Peeters
    7. -

      12 months results of the PREVENT study: investigating the Everolimus-eluting stent in BTK lesions in CLI patients

        Marc Bosiers
    8. -

      Live case transmission from Leipzig

    9. -

      Calcification of BTK arteries: The scope of the problem and attempts to solve it

        Jihad Mustapha
    10. -

      Bioabsorbable drug-eluting scaffolds in BTK arteries: Update on the ABSORB BTK project

        Ramon Varcoe
    11. -

      Future concepts for drug delivery

        Michael Jaff
    12. -

      The LIMBO project: Micropuncture mediated adventitial drug infusion to prevent restenosis in BTK arteries

        George Adams
    13. -

      Tack optimized balloon angioplasty below the knee (TOBA-BTK) 6 months results: A new method for treating CLI patients with post-PTA dissections

        Marianne Brodmann
    14. -

      Remaining challenges and future concepts: Will drug-eluting balloons ever work in BTK arteries? - R. Virmani

  • Tuesday, January 26th: - , Room 1 - Main Arena 1

    The last frontiers: Calcified lesions

    Moderator:
    Gary Ansel, Marianne Brodmann
    Panel:
    Andrew Holden, Ayman Al-Sibaie, Craig Walker, Jean-Paul de Vries, Spiridon Botsios, Ammanulla Bolia
    1. -

      Patterns of vessel calcification and clinical relevance

        Michael Jaff
    2. -

      Crossing techniques for calcified CTOs

        Andrew Holden
    3. -

      Live case transmission from New York

    4. -

      WHAT IS THE BEST CONCEPT TO DEAL WITH SEVERE CALCIFICATION?

    5. -

      Remove it! – Update on atherectomy techniques for calcified lesions

        Lawrence Garcia
    6. -

      Just stent it! – Biomimetic interwoven stents

        Craig Walker
    7. -

      Disrupt it! – The Shockwave lithotrypsie concept

        Thomas Zeller
    8. -

      Go around it! – The percutaneous bypass technique

        Andrej Schmidt
    9. -

      Recorded case: Shockwave lithotrypsie

        Marianne Brodmann
    10. -

      Live case transmission from Leipzig

  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    Symposium: The evolution of peripheral arterial interventions and the revolution in drug eluting technologies

    Moderator:
    Dierk Scheinert
    Panel:
    Michael Lichtenberg, Nicolas Shammas, Jaydeep Kokate, Thomas Zeller
    1. -

      Introduction by the moderator

    2. -

      State of play – contemporary use of DCB and Ranger Investigator Sponsored Research

        Michael Lichtenberg
    3. -

      Hello again – re-intervention strategies for sub-optimal results of current technologies

        Nicolas Shammas
    4. -

      Live case transmission from Berlin

    5. -

      Eluvia – designing a revolutionary drug eluting stent for SFA intervention

        Jaydeep Kokate
    6. -

      Setting a new benchmark – Eluvia clinical results and ongoing studies

        Thomas Zeller
    7. -

      Conclusion by the moderator

  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    Venous interventions: Current status and open questions

    Moderator:
    Gary Ansel, Iris Baumgartner
    Panel:
    Michael Jaff, Rupert Bauersachs, Michael Lichtenberg, Cees Wittens, William Gray, Ralf Kolvenbach
    1. -

      Intervention for DVT and PE – a revolution in the making

        Michael Jaff
    2. -

      Status of anticoagulation therapy in 2016: Is there a need for venous revascularization?

        Rupert Bauersachs
    3. -

      Current evidence for deep venous interventions

        Iris Baumgartner
    4. -

      Live case transmission from Berne

    5. -

      Techniques for thrombus removal in acute DVT

        Michael Lichtenberg
    6. -

      Interventions in the chronic setting with post-thrombotic syndrome

        Cees Wittens
    7. -

      Thrombus removal in acute pulmonary embolism – when and how?

        Kenneth Rosenfield
    8. -

      Innovative endovascular approach to pulmonary embolism by ultrasound enhanced thrombolysis

        Ralf Kolvenbach
    9. -

      Endovenous interventions for varicose vein disease – current status

        Raghu Kolluri
    10. -

      Discussion

  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    Symposium: How to treat complex peripheral lesions with confidence

    Moderator:
    Daniele Savio
    Panel:
    Michel Reijnen, Peter Soukas, Fabien Thaveau, Jeffrey Y. Wang, Darren Schneider
    1. -

      Introduction by the moderator

    2. -

      Treating challenging lesions: the importance of flexibility and accuracy

        Fabien Thaveau
    3. -

      Live case transmission from Leipzig

    4. -

      In-stent restenosis: What is the impact of reintervention? What is the choice of therapy costing you?

        Jeffrey Y. Wang
    5. -

      Live case transmission from Dendermonde

    6. -

      Lessons learnt when treating complex lesions using an endoluminal bypass

        Darren Schneider
    7. -

      Discussion and conclusion by the moderator

  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    Latest pharmacological innovations for peripheral arterial disease: How to optimize the outcome of peripheral revascularization?

    Moderator:
    Dierk Scheinert
    Panel:
    Michael Jaff, Frans Moll, Rupert Bauersachs, Marco Roffi, Dariusz Dudek
    1. -

      Introduction by the moderator

    2. -

      What is best medical therapy in PAOD and is there a need for better concepts and more data?

        Michael Jaff
    3. -

      The EPAD-Study: RCT comparing endoxaban and aspirin to clopidogrel and aspirin in SFA and proximal popliteal interventions

        Frans Moll
    4. -

      The VOYAGER trial: RCT investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic PAOD undergoing revascularization

        Rupert Bauersachs
    5. -

      Discussion and conclusion

  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    Symposium: LUTONIX® DCB – clinical evidence and real life experiences in SFA, BTK & AV indications

    Moderator:
    Dierk Scheinert
    Panel:
    Fabrizio Fanelli, Sabine Steiner
    1. -

      A study of downstream events of the two leading DCBs on the market - R. Virmani

    2. -

      LUTONIX® DCB in SFA – insights of the LEVANT 2 & real world outcomes from the global registry

        Fabrizio Fanelli
    3. -

      LUTONIX® DCB in SFA – insights of the LEVANT 2 German cohort

        Dierk Scheinert
    4. -

      Live case transmission from Leipzig

    5. -

      LUTONIX® DCB in BTK – Update on the BTK clinical program & single center experience

        Sabine Steiner
    6. -

      LUTONIX® DCB in AV access – a single center experience

        Dimitrios Karnabatidis
    7. -

      LUTONIX® DCB in AV access – a single center experience

        Kate Steiner
  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    VIVA @ LINC: Next steps in carotid revascularization

    Moderator:
    Peter Schneider
    Panel:
    William Gray, Sean Lyden, Kenneth Rosenfield, Raghu Kolluri
    1. -

      Announcement of the Vascular Career Advancement Award Recipients: R. Kolluri, Th. Bisdas

        Giancarlo Biamino, Peter Schneider
    2. -

      How should studies be designed to evaluate new carotid protection devices and stents?

        William Gray
    3. -

      Live case transmission from Kingsport

    4. -

      Is proximal protection the way forward? Options, techniques and results

        Gary Ansel
    5. -

      Will mesh covered stents help reduce the risk of stroke?

        Peter Schneider
    6. -

      Live case transmission from Kingsport

    7. -

      Carotid revascularization 20 years from now

        Kenneth Rosenfield
  • Wednesday, January 27th: - , Room 1 - Main Arena 1

    The last frontiers: In-stent restenosis, popliteal and long lesions

    Moderator:
    Patrick Peeters, William Gray
    Panel:
    Hans Krankenberg, Peter Schneider, Roberto Ferraresi, Klaus Amendt, Johannes Lammer
    1. -

      DEBATE: MECHANICAL BARRIER VS. DRUG-ELUTION FOR TREATMENT OF IN-STENT RESTENOSIS

    2. -

      Pro drug-elution

        Hans Krankenberg
    3. -

      Pro mechanical barrier

        Peter Soukas
    4. -

      The Lutonix global drug coated balloon registry: 12 months results of the ISR subgroup

        Chris Metzger, Via satellite from Kingsport
    5. -

      Biology of in-stent restenosis and rational for debulking

        Jos van den Berg
    6. -

      Live case transmission from Leipzig

    7. -

      Is flexed knee study useful in popliteal artery angioplasty?

        Roberto Ferraresi
    8. -

      Spot-stenting – Multi-LOC theoretical background and first real world results

        Klaus Amendt
    9. -

      Initial results of the ZILVERPASS study: A RCT investigating the Zilver PTX DES vs. bypass surgery for femoropopliteal TASC C&D lesions

        Marc Bosiers
    10. -

      Popliteal artery lesions: How do I decide between DCB, stenting, atherectomy or bypass

        Peter Schneider
    11. -

      SuperB trial: a prospective randomized study comparing endoluminal bypass to surgery

        Michel Reijnen
    12. -

      Live case transmission from Kingsport

  • Thursday, January 28th: - , Room 1 - Main Arena 1

    The last frontiers: Retrograde tibial interventions and below-the-ankle angioplasty

    Moderator:
    Gary Ansel
    Panel:
    Jihad Mustapha, Kazushi Urasawa, Roberto Ferraresi, Steven Kum, Hiroyoshi Yokoi
    1. -

      Live case transmission from Leipzig

    2. -

      THE RETROGRADE TIBIAL PUNCTURE

    3. -

      Ultrasound guided technique

        Jihad Mustapha
    4. -

      Fluoroscopy-guided technique

        Andrej Schmidt
    5. -

      The anatomy of pedal vasculature and principles for pedal intervention

        Thomas Rand
    6. -

      Live case transmission from Abano Terme

    7. -

      Advanced wiring techniques for below-the-knee and below-the-ankle interventions

        Hiroyoshi Yokoi
    8. -

      Implications of the wound related artery concept for BTK revascularization strategies: When and how to do pedal interventions?

        Roberto Ferraresi
    9. -

      Results of 999 BTK angioplasty procedures from a tertiary high-volume diabetic foot center

        Alberto Cremonesi, Antonio Micari
  • Thursday, January 28th: - , Room 1 - Main Arena 1

    Symposium: Advancing DCB therapy in complex SFA lesions

    Moderator:
    Craig Walker
    Panel:
    Henrik Schröder, Erwin Blessing, Fabrizio Fanelli, Eric Dippel
    1. -

      DCB towards standard of care: Evidence Status of DCBs in SFA

        Thomas Zeller, Via satellite from Bad Krozingen
    2. -

      The when and why of pre-dilatation before DCB: lessons from ILLUMENATE FIH

        Henrik Schröder
    3. -

      Live case transmission from Bad Krozingen

    4. -

      Plaque scoring in calcified lesions

        Erwin Blessing
    5. -

      Live case transmission from Leipzig

    6. -

      Photoablation and DCB in in-stent restenosis

        Craig Walker
  • Thursday, January 28th: - , Room 1 - Main Arena 1

    Symposium: The Lumivascular future: Image-guided therapy with Pantheis and Ocelot

    Moderator:
    Marianne Brodmann
    Panel:
    Suhail Dohad, Ian Cawich, Jeffrey G. Carr
    1. -

      Introduction by the moderator

    2. -

      OCT for peripheral vascular intervention

        Suhail Dohad
    3. -

      Lumivascular case series

        Marianne Brodmann
    4. -

      Live case transmission from Münster

    5. -

      Applying Lumivascular in the office based lab setting

        Jeffrey G. Carr
    6. -

      VISION 6 month data outcomes

        Ian Cawich
    7. -

      Live case transmission from Münster

    8. -

      Discussion and conclusion

  • Thursday, January 28th: - , Room 1 - Main Arena 1

    Lunch symposium: Moving the boundaries of BTK treatment

    Panel:
    Jihad Mustapha, Yann Gouëffic, Francesco Liistro
    1. -

      Retrograde first

        Jihad Mustapha
    2. -

      Live case transmission from Leipzig: Retrograde tibial puncture step-by-step

        Andrej Schmidt
    3. -

      Multidisciplinary approach to BTK

        Yann Gouëffic
    4. -

      How far to go to save the diabetic foot

        Francesco Liistro
    5. -

      Wrap-up live case and discussion

  • Thursday, January 28th: - , Room 1 - Main Arena 1

    LINC Expert Course: Pioneering techniques for CLI and CTOs (Part I) - with Marco Manzi live from Abano Terme - with Thomas Zeller live from Bad Krozingen - with Andrej Schmidt live from Leipzig

    live:
    Marco Manzi, Thomas Zeller, Andrej Schmidt
    Moderator:
    Marc Bosiers, Stephan Duda
    Panel:
    Erwin Blessing, Jos van den Berg, Kazushi Urasawa, Steven Kum
    1. -

      Flash presentation: IVUS-guided DES implantation for treating long SFA-CTOs

        Hiroyoshi Yokoi
    2. -

      Flash presentation: Update on bi-directional wiring techniques to recanalize long SFA occlusions

        Kazushi Urasawa
    3. -

      Flash presentation: The Wingman CTO catheter: First experience with a new CTO renanalization needle device

        Michael Lichtenberg
    4. -

      Flash presentation: Micro-Mesh stent technology – also a solution for peripheral arteries?

        Daniel Périard
    5. -

      Flash presentation: Treatment of embolic complications in vascular interventions

        Jos van den Berg
  • Thursday, January 28th: - , Room 1 - Main Arena 1

    Controversies, challenges and new concepts in renal and visceral interventions and concepts for patients with chronic kidney disease

    Moderator:
    Ramon Varcoe, Klaus Mathias
    Panel:
    Kenneth Rosenfield, Dariusz Dudek, Roland E. Schmieder, Felix Mahfoud, Eberhard Wedell, Craig Walker
    1. -

      Endovascular treatment of renal and visceral aneurysms

        Michael Dake
    2. -

      Does no one talk about renal artery stenting anymore?

        Kenneth Rosenfield
    3. -

      The concept of renal artery denervation – dead or alive?

        Dariusz Dudek
    4. -

      Live case transmission from Bad Krozingen

    5. -

      Externally delivered focused ultrasound for renal denervation

        Roland E. Schmieder
    6. -

      The next step in the interventional treatment of hypertension: SPYRAL HTN global clinical trial program

        Felix Mahfoud
    7. -

      Rescue procedures in acute visceral ischemia

        Yvonne Bausback
    8. -

      Live case transmission from Teaneck

    9. -

      Preventing contrast induced nephropathy: Technical solutions, and clinical utility of CO2 angiography

        Ulf Teichgräber
    10. -

      Contrast saving strategies for BTK recanalisation with the ARROWGPSCath

        Costantino del Giudice
  • Thursday, January 28th: - , Room 1 - Main Arena 1

    LINC Expert Course: Pioneering techniques for CLI and CTOs (Part II) - with Thomas Zeller live from Bad Krozingen - with John Rundback live from Teaneck

    live:
    Thomas Zeller, John Rundback
    Moderator:
    Kenneth Rosenfield, Steven Kum
    Panel:
    Ralf Langhoff, Jihad Mustapha, Miguel Montero-Baker, Andrej Schmidt, Peter Huppert
    1. -

      Flash presentation: CTO-crossing based on cap morphology

        Jihad Mustapha
    2. -

      Flash presentation: The value of C-arm perfusion CT to validate angiosom-guided revascularization

        Peter Huppert
    3. -

      Flash presentation: Office based assessment of changes in perfusion after endovascular Interventions in CLI patients with Indocyanin Green angiography

        Larry Diaz-Sandoval
    4. -

      Flash presentation: Technical overview of percutaneous deep vein arterialisation – The LimFlow procedure

        Andrej Schmidt
    5. -

      Flash presentation: Implantable microsensors to measure oxygen saturation: A new approach to assess procedural outcomes?

        Miguel Montero-Baker
  • Friday, January 29th: - , Room 1 - Main Arena 1

    Critical issues and pioneering solutions in aortic endografting

    Moderator:
    Andrea Stella, Martin Malina
    Panel:
    Thomas Nolte, Roberto Chiesa, Wolfgang Ritter, Thomas Larzon, Frank Criado, Michael Jacobs
    1. -

      Live case transmission from Münster

    2. -

      Chimneys and parallel grafts will remain useful for many years to come: Summary of current techniques and results

        Frank Criado
    3. -

      Nexus aortic arch stent-graft system: early results of the on-going studies

        Mario Lachat
    4. -

      Experience with the new Thoraflex graft for aortic arch replacement

        Friedrich Wilhelm Mohr
    5. -

      How to overcome obstacles in treating chronic aortic dissections?

        Thomas Larzon
    6. -

      Open and endovascular treatment of Lusorian artery

        Michael Jacobs
    7. -

      Live case transmission from Leipzig

    8. -

      Challenging endovascular treatment of Lusorian artery PAU

        Sven Seifert
    9. -

      Minimal invasive segmental artery coil embolization to prevent spinal cord ischemia after EVAR of TAAA

        Daniela Branzan
    10. -

      Homografts for mycotic aneurysms and infected grafts: summary of techniques and outcomes

        Olaf Richter
    11. -

      Long-term follow-up of semi-conservative treatment of mycotic aneurysms and graft infections: Is radical surgery really justified?

        Martin Malina
    12. -

      2 in 1 stentgraft to reduce aortic coverage in T-Branch

        Piotr Kasprzak
    13. -

      Live case transmission from Münster

    14. -

      Discussion and conclusion

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

more info
  • Strictly necessary

    We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • Analytical (Tracking) Cookies

    We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Functionality Cookies

    Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.